Ferring today published its 2025 Annual Report and Sustainability Report. The company achieved total revenues of over €2.5 billion in 2025, an increase of 7% over the previous year at actual exchange ...

No specific interactions have been reported for Menopur, a fertility medication that contains hormones. But no reported interactions doesn’t mean “no risk.” Menopur manufacturer’s prescribing ...

Slimming injections are booming, but how they work, their side effects, and actual weight loss vary. Here’s what you need to know. The past year has completely changed the way we view obesity. Whereas ...

New hypertension treatments may reduce dosage to two injections annually instead of daily pills Zilebesiran uses siRNA to lower blood pressure by targeting angiotensinogen production in the liver Long ...

The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Prompt injection attacks can manipulate AI behavior in ways that traditional cybersecurity ...

The cost of Menopur can vary depending on factors like pharmacy and insurance coverage, and it may require purchase through a specialty pharmacy. Menopur is a biologic drug, and there is no cheaper ...

Infertility happens when you are not able to get pregnant after having regular, unprotected sex. Infertility can happen for many reasons, such as hormone problems, blocked fallopian tubes, or when a ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them ...